Pharma Mar S.A.
Biopharmaceutical company developing oncology treatments from marine sources.
PHM | MC
Overview
Corporate Details
- ISIN(s):
- ES0169501022 (+1 more)
- LEI:
- 959800QWKZ45ZQC2AV58
- Country:
- Spain
- Address:
- Avenida de los Reyes 1 Polígono Industrial La Mina, 28770 Colmenar Viejo
- Website:
- https://pharmamar.com/en/
- Sector:
- Manufacturing
Description
Pharma Mar S.A. is a biopharmaceutical company specializing in the discovery, development, and commercialization of oncology treatments derived from marine sources. A pioneer in its field since 1986, the company leverages marine biodiversity to develop innovative therapies for cancer, with a particular focus on rare tumors. Its integrated R&D pipeline spans from the exploration of marine invertebrates to the marketing of approved drugs. The company maintains an extensive collection of over 500,000 marine samples, which serves as the foundation for its drug discovery programs. Key commercialized products include Yondelis® (trabectedin) for advanced soft tissue sarcoma and ovarian cancer, Zepzelca® (lurbinectedin) for small cell lung cancer, and Aplidin® (plitidepsin) for multiple myeloma.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-01-06 11:12 |
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa d…
|
Spanish | 230.8 KB | ||
| 2024-12-30 17:47 |
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa d…
|
Spanish | 206.0 KB | ||
| 2024-12-20 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2024-12-19 08:55 |
La Sociedad finaliza el reclutamiento del estudio fase III LAGOON con Zepzelca®…
|
Spanish | 737.8 KB | ||
| 2024-12-19 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2024-12-18 17:48 |
La Sociedad informa que llevará a cabo un programa de recompra de acciones prop…
|
Spanish | 155.4 KB | ||
| 2024-12-18 17:41 |
La Sociedad informa de la aprobación de los Reglamentos de la Comisión de Audit…
|
Spanish | 153.3 KB | ||
| 2024-12-12 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2024-11-21 17:39 |
Inscripción en el Registro Mercantil de Madrid del acuerdo de reducción de capi…
|
Spanish | 153.5 KB | ||
| 2024-11-20 12:22 |
La Sociedad informa que el Tribunal General de la Unión Europea ha declarado el…
|
Spanish | 728.1 KB | ||
| 2024-11-05 08:27 |
La Sociedad anuncia que ha recibido por parte de Janssen Products LP un pago de…
|
Spanish | 719.9 KB | ||
| 2024-10-29 17:43 |
Ejecución de la reducción de capital mediante amortización de acciones propias …
|
Spanish | 157.2 KB | ||
| 2024-10-29 17:38 |
La Sociedad publica información financiera correspondiente al tercer trimestre …
|
Spanish | 826.1 KB | ||
| 2024-10-21 00:00 |
Motivo de la notificación: Persona Estrechamente Vinculada
|
Spanish | 91.4 KB | ||
| 2024-10-15 13:33 |
Pharma Mar anuncia resultados positivos del ensayo de fase III que evalúa Zepze…
|
Spanish | 781.8 KB |
Automate Your Workflow. Get a real-time feed of all Pharma Mar S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharma Mar S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharma Mar S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
